SY stock — So-Young International Inc. insiders and 13F holders
SY
So-Young International Inc.
NASDAQ· Healthcare· Health Information Services· CUSIP 83356Q108
$2.40▲ +3.45%Price as of Aug 29, 18:32 UTC · updated once a day, after the close
Key metrics
Market cap
$240.91M
P/E
—
Forward P/E
—
P/B
1.1x
Dividend yield
—
Payout
—
EPS
-$0.38
ROE
-15.04%
Profit margin
-15.57%
Revenue growth
+45.60%
Beta
2.06
52-week high
$4.75
52-week low
$1.28
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
Equity, revenue and profitEquityRevenueNet income
findstockfast.com
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Revenue7 years
findstockfast.com
Net debtDebt minus cash — below zero means more cash than debt
findstockfast.com
Dividend per share2 years
findstockfast.com
Dividend growthYear over year, complete years only — a year still running would show a fall that has not happened.
findstockfast.com
Investors holding this
Major managers that reported this stock in their latest 13F.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 7 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
Indicator
Median
2025
2024
2023
2022
2021
2020
2019
Year-end price
$2.56
$0.83
$1.29
$1.29
$3.19
$11.11
$12.22
P/E
—
—
—
33.6x
—
—
1044.7x
30.5x
P/S
0.9x
0.9x
0.3x
0.5x
0.6x
1.0x
3.9x
4.7x
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.